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Available online 17 February 2013Mate (Ilex paraguariensisA. St.-Hil) is a native species of SouthAmerica used to prepare traditional
beverages. Recently a possible effect of its infusion on oxidative stress found in dyslipidemias has
been reported. The main compounds related to these activities are phenolic compounds derived
from chlorogenic acid. This study aimed to determine the anticholesteremic effect of the
hydroethanolic extract (HEIP) and its n-butanolic fraction (n-BFIP), with standardized content of
phenolic compounds derived from chlorogenic acid, in rats treated with high-fat diet (HFD). The
contents of these compounds in the ethanol extract and n-butanol fractionwere respectively two
and three times higher than in traditional infusion with predominance of dicaffeoylquinic
derivatives. The extracts were able to reduce serum triglycerides and cholesterol and decrease the
atherogenic index in treated animals. These results support a potential effect of the mate extract
in cardiovascular disease.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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The prevalence of overweight and obese individuals
worldwide has increased dramatically due to, in large part,
the over consumption of a high-fat diet (HFD) [1,2]. A HFD
has been shown to cause an elevation of plasma lipids,
including cholesterol levels [3]. The two most common
components of cholesterol are low-density lipoproteins
(LDL) and high-density lipoproteins (HDL), and elevated
serum levels of LDL cholesterol and reduced levels of HDL
cholesterol are important independent risk factors for
cardiovascular disease (CVD) [4]. Therefore, the control of
postprandial LDL and HDL has been shown to be important in
the treatment of CVD and in the prevention of atherosclero-
sis. Several publications have reported that the naturalrmacologia de Produtos
uza 3636, Toledo, PR
).
lsevier OA license.products have a beneficial effect on CVD and atherosclerosis
by regulating multiple epigenetic mechanisms, including the
levels of HDL and LDL cholesterol [5]. These reports have
demonstrated a reduction in the incidence of CVD and
atherosclerosis associated with obesity by natural product
therapy.
Mate (Ilex paraguariensis A. St.-Hil., Aquifoliaceae) is a
native species of the subtropical regions of South America. The
leaves are used to prepare traditional beverages (chimarrão,
mate and tererê) especially in Brazil, Argentina, Uruguay and
Paraguay [6]. Recently it has been used in the development of
food and cosmetic products and a review of the importance of
this species was published [7,8].
Previous work [9] about the chemical composition of this
species showed the presence of methylxanthines — caffeine
and theobromine, the average content of caffeine in mate
ranged from 0.315 to 0.667% and theobromine of 0.037 to
0.237%. In addition, there is the presence of numerous
triterpenic saponins derived from ursolic and oleanolic acids.
Different saponins (triterpene oligoglycosides) were identified
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several of these compounds showed inhibitory activities on
pancreatic lipase [10]. The presence of flavonoids and vitamins
such as B1 (thiamine), B2 (riboflavin), B5 (pantothenic acid), C,
E, β-carotene, sucrose, fructose, folic acid, trigonelline and
choline has also been reported [7].
In recent years, the importance of phenolic compounds in
biological activity of I. paraguariensis has been highlighted.
Phytochemical analyses performed by different methods have
shown average levels of phenolic compounds could vary
between 7.9 and 9.6% [9,11–16]. The phenolic compounds
of major importance in mate refer to caffeoyl derivatives,
mainly monocaffeoyl quinic isomers (3-O-caffeoyl quinic or
neochlorogenic acid, 5-O-caffeoyl quinic or chlorogenic acid
and 4-O-caffeoyl quinic or cryptochlorogenic acid) and
dicaffeoyl quinic isomers (3,4-dicaffeoylquinic acid, 3,5-
dicaffeoylquinic acid and 4,5-dicaffeoylquinic acid). Moreover,
the levels of phenolic compounds are modified according to
extractive methods, [11,14,17], processing, genetic and envi-
ronmental variability, and harvest time [18].
Mate infusion has been used in folk medicine for the
treatment of arthritis, rheumatism and other inflammatory
diseases, headache, obesity, hypertension, and digestive disor-
ders [6]. Several biological activities ofmate are associatedwith
the phenolic compounds and some researchers have shown
the inhibition of LDL oxidation in vitro and in vivomodels [19].
Mate extracts inhibited the enzymatic and nonenzymatic
lipidic peroxidation aswell as it was effective in othermethods
to evaluate the in vitro antioxidant effect [20–23]. Studies
demonstrate that an aqueous extract of I. paraguariensis and l.
brasiliensis protects the myocardium against ischemia–reper-
fusion injury and attenuates oxidative damage. These effects
may be attributed to the potent antioxidant properties of the
extract [24,25]. Furthermore, I. paraguariensis aqueous extract
effectively inhibited the progression of atherosclerosis in
cholesterol-fed-rabbits [6] and reduced the body weight,
visceral fat, serum lipids, glucose, leptin and insulin levels in
HFD-fed-rats [26]. Recent studies indicate the chlorogenic acid
as one of the main responsible for this activity [27,28].
Considering the data presented above and the importance of
phenolic compounds in the cardioprotective effects of mate, we
propose to develop and standardize a fraction enriched in
phenolic compounds from the ethanol extract of I. paraguariensis
and investigate their effectiveness on body weight and serum
lipid levels of rats submitted to high-fat diet.
2. Materials and methods
2.1. Drugs
Caffeine, theobromine, chlorogenic acid and cholic acidwere
obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA).
Cholesterol was obtained fromVetec Fine Chemicals (São Paulo,
Brazil). Simvastatin fromSigma (St. Louis,MO, USA)was used as
the reference hypolipidemic drug. All other drugs and reagents
used were purchased from J. T. Backer (USA) and Vetec.
2.2. Collection of plant material
Mate leaves (I. paraguariensis St. Hil.) were obtained from
experimental cultivated progenies to guarantee the contentof methylxanthines and phenolic compounds as previously
described [18]. The cultivation is located in the municipality
of Ivai/PR, Brazil, which is located at 650–750 m altitude
above the sea level (S 25°01′–W 50°47′).
2.3. Preparation of I. paraguariensis extracts
Mate leaves' powderwas dried in a forced draft oven (45 °C,
48 h). The infusion of the leaves (0.1 g:10 ml) was obtained
using aqueous extraction. Another fraction of the sample was
extractedwith 70% ethanol (1:2.5 w/v), filtered and evaporated
to dryness, to obtain the crude extract (HEIP). The HEIP was
fractionated by liquid/liquid partitioning (n-hexane, chloro-
form, ethyl acetate and n-butanol), obtaining the n-butanol
fraction (n-BFIP). These extracts (HEIP and n-BFIP)were used to
evaluate the pharmacological activity.
2.4. Phytochemical analysis
2.4.1. Apparatus and chemicals
The analysis was performed by a Shimadzu (Mod. SCL-10A)
high performance liquid chromatography coupled with diode
array detector (HPLC-DAD) consisting of a SIL-20AHT injector,
a LC-20AT pump, an FCV-10AL mixer, a DGU-20A5 degasser
and an injector valve, a 20 μl sample loop. A SPD-M20A DAD
detector coupled to the chromatograph and an interphase
module Shimadzu CBM-20A. A 5 μm Phenomenex C-18,
4.6×250 mm analytical column was used. The column was
maintained at 30 °C using the CTO-20A HPLC integrated oven.
2.4.2. Procedure
Sample of infusion (0.1 g/10 ml) [9], ethanol extract
(0.05 g/10 ml) and n-butanol fraction (0.05 g/10 ml) were
filtered with 0.45 μm nylon filters and the solvent system
consisted of (A) acidulatedwater purified by theMilli-Q system
(MiliporeMilford,MA),with 0.3% acetic acid, and (B)methanol.
The solvents were run at a flow rate of 1.0 ml min−1 using the
following linear gradient: 15% B to 20% B for 20 min, 20% B to
40% B for 25 min, 40% B to 85% B for 50 min, and 85% B to 15%B
for 10 min. Detection was monitored at 265 nm for caffeine
and theobromine, and at 325 nm for chlorogenic acids. All
samples were run in duplicate. Chromatographic peaks were
identified by comparing retention times with those of caffeine,
theobromine and chlorogenic acid standards recorded in the
same conditions. Calibration curves were obtained with the
mentioned standards after dilution in the mobile phase.
Linearity was determined by regression and precision and
accuracy was determined using the variation coefficient
(CVb3%). The correlation coefficients obtained were as follows
r2=1.0 for caffeine, r2=0.9942 for theobromine and r2=
0.9999 for chlorogenic acid. The contents of the caffeoyl
derivativeswere expressed in (5-O-caffeoyl quinic) chlorogenic
acid absorbance (mg/g).
2.5. Pharmacologic activity
2.5.1. Animals
Male Wistar rats (8 weeks-old, weighting between 250 and
300 g) from the colony of theUniversidadeParanaense (UNIPAR,
Paraná, Brazil) were used. All animals were maintained under
standard laboratory conditions, with a constant 12 h light/dark
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food (Nuvital®, Curitiba/PR, Brazil) and water were available ad
libitum. All experimental procedures adopted in this study were
previously approved by the Institutional Ethics Committee of the
Universidade Paranaense (no 18620/2010).2.5.2. Induction of hyperlipidemia
Animals were turned hyperlipidemic by giving high-fat
diet (HFD), for 60 days. The HFD contained cholesterol (2%)
and cholic acid (0.2%) as major constituents. Hyperlipidemia
was confirmed by measuring the levels of serum lipids and
lipoproteins in the rats.2.5.3. Experimental design
Fifty-five male Wistar rats were divided into 9 groups
with 5–7 animals in each group. The first group was fed with
standard laboratory diet and identified as negative control.
Then, different groups of rats received a HFD (for 30 days)
and were treated for more 30 days, per oral route, with
vehicle, HEIP (200, 400 and 800 mg/kg/day), n-BFIP (200,
400 and 800 mg/kg/day) or simvastatin (SVTN 20 mg/kg/day).
All tested drugs were dissolved in distilled water before
administration. Body weights (BW) (twice per week), serum
lipid levels, and atherogenic index were measured on the 60th
day after the treatment.2.5.3.1. Serum lipid proﬁle. Different groups of rats were
anesthetized with ketamine (100 mg/kg) and xylazine
(20 mg/kg) and blood samples were collected in heparin-
coated tubes after puncture of the inferior vena cava. Plasma
was obtained by centrifugation (1000 g, 15 min, 4 °C) and
stored at−20 °C until its analysis. The levels of triglyceride
(TG), total cholesterol (TC) and high-density lipoprotein
cholesterol (HDL-C) were measured using biochemical test
kits with the semi auto analyzer by colorimetric method.
The serum levels of low-density lipoprotein cholesterol
(LDL-C) and very low-density lipoprotein cholesterol
(VLDL-C) were calculated using the formula of Friedewald
[29].2.5.3.2. Atherogenic index (AIS). The atherogenic index serum
(AIS), which is the measure of the atherosclerotic lesion
extent based on serum lipids, was determined in all groups.
The atherogenic index is calculated using the formula AIS=
TC/HDL [30].2.6. Statistical analysis
The results are expressed as mean±standard error of
mean (S.E.M.) of 5–7 animals per group. Statistical analyses
were performed using one-way analysis of variance (ANOVA)
followed by Bonferroni's test. A p value less than 0.05 was
considered statistically significant. The graphs were drawn
and the statistical analyses were performed using GraphPad
Prism version 5.0 for Windows (GraphPad Software, San
Diego, CA, USA).3. Results
3.1. Phytochemical analysis
The I. paraguariensis extracts were analyzed by HPLC-DAD
obtaining the typical chromatograms (Fig. 1). The use of
external standard allows the identification of caffeine,
theobromine, chlorogenic acid and other compounds which
were monitored by diode-array detection. The identification
of the major compounds is possible through the analysis of
UV spectra and chromatographic profiles compared to
literature data. Methylxanthines are identified in the chro-
matogram (Fig. 1A) with peaks at 4.948 to theobromine and
11.927 to caffeine. The compound with a peak at 9.706
(Fig. 1B) corresponds to the chlorogenic acid, which corre-
sponds to caffeic acid esterified to quinic acid (5-O-caffeoyl
quinic acid), from the comparison to an external standard.
The UV spectra (Fig. 2B) of this compound showed maximum
at 329 nm and a shoulder at 296 nm, typical of caffeic acid
derivatives [11].
The compounds P-01with peak at 5.878 and P-03with peak
at 11.261 also exhibit similar UV spectra to the external standard
(Fig. 2A and C). Based on the UV spectra it is possible to say that
the compounds identified are caffeoyl quinic acid derivatives.
Besides, previous studies [11,12,31] cite the presence of 3- and
4-O-caffeoyl isomers of I. paraguariensis extracts. Considering
the UV spectra and the elution chromatographic profile of the
compounds on C-18 HPLC columns reported in the literature
[11], P-01 and P-03 compounds were characterized as
3-O-caffeoyl quinic acid (neochlorogenic acid) and 4-O-caffeoyl
quinic acid (cryptochlorogenic acid), respectively.
Similarly to the above compounds, P-04 and P-05 the
compounds exhibited a UV spectra similar to the external
standard (Fig. 2D and E), with maximum at 330 nm and a
shoulder at 296 nm. As monocaffeoyl derivatives, the pres-
ence of dicaffeoyl quinic isomers has also been reported
previously in mate. Other authors [11,12,16] showed the
preponderance of these compounds in mate extracts. Con-
sidering the retention times and elution profile in C-18 HPLC
columns reported for dicaffeoyl quinic acid isomers [16],
peaks at 38.747 (P-04 compound) and 44.852 (P-05
compound) were characterized as 3,4-dicaffeoylquinic acid
and 3,5-dicaffeoylquinic acid. The average content of these
compounds in the extracts is described in Table 1. Extracts of
mate are rich in triterpenoid saponins, besides the presence
of methylxanthines and caffeoyl quinic acids. The quantifica-
tion of saponins was not the objective of this work, despite
the biological importance of these compounds.
3.2. Lipid proﬁle
Total serum cholesterol of negative controls (baseline 80±
4.8 mg/dl) was increased to 127±6.5 mg/dl in the positive
controls (HFD) after 60 days. At the same time, the values for
SVTN treated-rats were significantly lowered to 85±7.1 mg/dl
when compared to positive controls (pb0.05). Similarly, a
significant reduction in the CT levels was also evident in HFD
rats treated with extracts from I. paraguariensis. In the animals
that received the HEIP (200 and 800 mg/kg) the CT was
reduced to levels of 97±6.4 and 97±7.7 mg/dl (pb0.05). In
the sameway, the groups treatedwith n-BFIP at doses 200 and
Fig. 1. Representative HPLC-DAD chromatogram of Ilex paraguariensis ethanol extract, (A) signal at 265 nm and (B) signal at 325 nm. Chromatographic conditions
are specified in Materials and methods. The indicated compounds are described in Table 1.
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3.6 mg/dl (Pb0.05), respectively (Table 2).
Likewise, n-BFIP-treated rats presented an expressive
reduction in serum LDL-C at doses of 200 and 400 mg/kg
(31±3.1 and 30±3.7, respectively; positive control: 57±
6.8; pb0.05). In addition, the values of VLDL-C were similarly
reduced in animals treated with HEIP (400 and 800 mg/kg)
or n-BFIP (200, 400 and 800 mg/kg), with an estimated
reduction in 41%. Still, changes in the HDL-C levels were
paralleled to CT in all the treated groups. In all groups in
which CT showed a significant reduction, the HDL levels were
similarly reduced (Table 2).
The oral administration of all tested drugs (HEIP and
n-BFIP) resulted in significantly reducing triglyceride levels
when compared to positive control group (positive control:
86±4.1; HEIP 400: 61±7.1; HEIP 800: 57±9.6; n-BFIP 200:
56±4.8; n-BFIP 400: 58±6.6; n-BFIP 800: 51±4.5 mg/dl;
pb0.05). In addition, the trygliceride levels measured in HEIP
and n-BFIP groups were close to that found in the SVTN group
(45±6.3 mg/dl). At long last, the body weight of the animals
fed with HFD and treated with n-BFIP (200 and 400 mg/kg)
showed a significant reduction in body weight in a direct
correlation with the serum lipids (Table 2).Fig. 2. Ultraviolet spectrum of each peak, established by the photo diode array d3.3. Serum atherogenic index
Serum atherogenic index was high in the HFD positive
control group (3.4±0.24) after the 60 days of treatment. The
treatment with I. paraguariensis extracts (HEIP and n-BFIP)
induced a significant reduction of atherogenic index when
compared to the HFD positive control group (Pb0.05). The
values found at doses of 400 and 800 mg/kg of HEIP were
2.6±0.14 and 2.5±0.20, respectively. Likewise, the rats
treated with n-BFIP (200 and 400 mg/kg) showed values of
2.4±0.18 and 2.2±0.16, respectively (close to that found in
the SVTN or negative control group) (Fig. 3).
4. Discussion and conclusions
There is substantial evidence from both in vitro and in vivo
studies regarding the beneficial effect of extracts obtained
from I. paraguariensis on oxidative stress, obesity and
dyslipidemias [8]. In the present work, the standardized and
active extract of I. paraguariensis (HEIP) was fractionated by
liquid/liquid partitioning obtaining the n-butanol fraction
(n-BFIP), which was analyzed by HPLC-DAD and UV spectra.
Additionally, it was sought to evaluate the role of phenolicetector. (A) P-01, (B) chlorogenic acid, (C) P-03, (D) P-04 and (E) P-05.
Table 1
Methylxanthines and caffeoyl quinic acids in mate (Ilex paraguariensis) extract (mg/g). (P-01)=3-O-caffeoyl quinic acid, (P-03) 4-O-caffeoyl quinic acid, (P-04)
3,4-dicaffeoylquinic acid (P-05) 3,5-dicaffeoylquinic acid.
Methylxanthines Caffeoyl quinic acids (CQA)
Caffeine Theobromine P-01 Chlorogenic acid P-03 P-04 P-05 ∑a Total caffeoyl derivatives (%)
Infusion 12.44 2.28 24.09 16.12 11.01 23.17 5.89 80.28 8.03
Crude Extract 19.25 7.68 24.18 33.57 31.12 47.47 44.17 180.51 18.05
n-Butanol Fraction 6.52 8.25 23.63 22.51 33.54 73.38 97.50 250.56 25.06
CQAs values expressed as chlorogenic (5-O-caffeoyl quinic) acid.
a Values are the sum of the different isomers detected in mate extracts.
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HFD rats.
The presence of methylxanthines in I. paraguariensis leaf
extracts is widely described in literature [7,8,14]. The process
of fractionation allowed changing the relationship of caf-
feine/theobromine, prioritizing the second compound. The
extraction process used in this work made it possible to
obtain a product with higher content of phenolic compounds
in comparison to traditional processes used in the consump-
tion of I. paraguariensis [16]. The fractionation has increased
the content of phenolic compounds, especially those
dicaffeoylquinic acid derivatives (3,4-dicaffeoylquinic acid
and 3,5-dicaffeoylquinic acid). Thus, the n-BFIP had approx-
imately three times more phenolic compounds when com-
pared to the infusion (Table 1). The results presented here
extended the previous data and showed, for the first time,
that active constituents present in the HEIP and in its n-BFIP
with a standardized content of phenolic compounds are
effective in inducing lipid-lowering effects in HFD rats.
Quantitatively, the mono-, di-, and tri-esters of hydroxy-
cinnamic acids and quinic acid are the major constituents
of the phenolic fraction of mate leaves. These compounds
are reported as major constituents of the phenolic fraction
of mate and the unequivocal identification of phenolic com-
pounds by LC-MS chromatography was performed recently
[11]. The chromatographic profile obtained by the authors
compared to literature data, allows the suggestion that the
main chromatographic peaks found belong to derivatives
of caffeoyl quinic acids, mono- and di-caffeoyl, respectively.
Another important aspect of the present work refers to the
content of major compounds in different extracts. Different
studies show the contents of caffeoyl quinic acids in mateTable 2
Effect of oral administration of Ilex paraguariensis ethanolic extract (HEIP), n-butano
experimental high-fat diet.
Group TC (mg/dl) HDL-C (mg/dl) LDL-C (mg/d
N. control 80±4.8 31±1.2 36±6.0
P. control 127±6.5b 35±1.4b 57±6.8b
SVTN 20 85±7.1a 31±1.7 49±8.5
HEIP 200 97±6.4a 30±1.7 a 53±6.3
HEIP 400 101±8.1 36±1.2b 53±8.1
HEIP 800 97±7.7a 34±1.4 51±6.2
n-BFIP 200 70±6.1a 26±1.9a 31±3.1a
n-BFIP 400 75±3.6a 28±2.0a 30±3.7 a
n-BFIP 800 104±7.0 32±2.6 40±3.2
Values are expressed as mean±S.E.M. (n=5–7 in each group) in comparison with th
ANOVA followed by Bonferroni test. TC (total cholesterol); HDL-C (high-density lip
(very low-density lipoprotein cholesterol); TG (triglyceride); BW (body weight).[9,11–14,31]. The concentration of caffeoylquinic acid de-
rivatives in I. paraguariensis extracts was calculated using the
calibration curves of the 5-O-caffeoylquinic acid, standards
closest in chemical structure [11]. The extractive methods
revealed differences in the levels of phenolic compounds
(Table 1). The crude extract obtained in this work presented
greater capacity to extract phenolic compounds (180.51 mg/g)
when compared to infusion (80.28 mg/g), and the fractionation
process increased the final concentration of these constituents
(250.56 mg/g). The majority of I. paraguariensis extract com-
ponents (80%) were represented by hydroxycinnamoyl quinic
acids [31]. The values expressed as percentages of total
phenolic compounds obtained are close to the values described
in previous papers (Table 1) to mate infusion [12] and crude
extract [18]. The ratio between the levels of different isomers
monocaffeoylquinic and dicaffeoylquinic is also close to values
reported by [11].
Several studies have reported the benefits of mate infusion
on lipid metabolism, obesity and oxidation [8,32]. This effect
may be due to strong protection of ex vivo human LDL-C from
oxidation aswell as protection of paraoxonase (PON1) activity,
which protects LDL-C from oxidation and reduces macrophage
oxidation and it is thus thought to be atheroprotective. In a
recent study [33] it was demonstrated that chlorogenic acid,
the main phenolic compound in I. paraguariensis infusion,
protects PON1 in human HDL-C from the inactivation caused
by physiological concentrations of hypochlorite. Likewise, the
consumption of I. paraguariensis extracts decreases the oxida-
tion of unsaturated fatty acids in the liver of mice [28], and
chlorogenic acid is involved in the process. In the other hand,
the saponins present in the infusion of I. paraguariensis may
also play a role in the control of dyslipidemia. Recently it waslic fraction (n-BFIP) and simvastatin (SVTN) on serum lipid profile in rats fed
l) VLDL-C (mg/dl) TG (mg/dl) BW (gain/g)
13±0.7 67±3.9 57±10
17±1.3b 86±4.1b 127±22b
9±1.2a 45±6.3a 95±13
13±0.9 67±4.4 97±8.0
11±0.9a 61±7.1a 132±11
10±1.9a 57±9.6a 120±15
11±0.9a 56±4.8a 59±3.3a
10±2.0a 58±6.6a 69±4.2a
10±0.9a 51±4.5a 88±9.0
e positive control (a; pb0.05) or negative control (b; pb0.05) using one-way
oprotein cholesterol); LDL-C (low-density lipoprotein cholesterol); VLDL-C
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Fig. 3. Ilex paraguariensis ethanolic extract (HEIP) (A) and their n-butanolic fraction (n-BFIP) (B) reduce the atherogenic index serum (AIS) after prolonged
treatment. Values are expressed as mean±S.E.M. of seven rats in each group in comparison with the positive control (a; pb0.05) or negative control (b; pb0.05)
using one-way ANOVA followed by Bonferroni test. AIS=TC (total cholesterol)/HDL-C (high-density lipoprotein cholesterol).
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could inhibit pancreatic lipase, an enzyme that plays an
important role in lipid digestion [10].
Dyslipidemias leading to coronary artery disease has
assumed a virulent ratio and is the main cause of morbidity
in the developed world as well as in the developing countries.
Epidemiologic studies have demonstrated a positive and
significant relationship between plasma cholesterol concen-
trations and coronary artery disease, where the main clinical
manifestation is plaque formation in the artery walls [34]. In
many cases, plaques protrude into the lumen of the artery
and if they are sufficiently large, compromise the blood flow.
One of the key steps in the development of atherosclerosis is
oxidative modification of LDL-C, which is scavenged by
macrophages leading to formation of foam cells in the vessel
wall, belonging to the early changes initiating the formation
of atherosclerotic plaque [35].
Synthetic lipid-lowering drugs like statins are used widely
for the treatment of hypercholesterolemia and prevention of
atherosclerosis. They inhibit HMG-CoA reductase competitive-
ly, reduce LDL-C levels more than other cholesterol-lowering
drugs, and lower triglyceride levels in hypertriglyceridemic
patients. In addition,mechanisms independent of LDL lowering
may play an important role in the clinical benefits conferred by
these drugs and may ultimately broaden their indication from
lipid-lowering to antiatherogenic agents [36]. Statins such as
simvastatin are widely used for the treatment of coronary
artery disease and for secondary prevention of stroke [37].
However, side effects such as liver and muscle toxicity have
been associated with the clinical use of statins [38].
This fact has led researchers to search for newmolecules or
herbal drugs with minor adverse effects. In this context, many
herbal hypolipidemic can produce lower acute toxicity and, in
general, could be considered as mild [39–41]. In our study,
using normotensive young Wistar rats, we found that animalsfrom HFD-fed groups displayed significantly increased body
weight and serum lipids, and disclosed that in HEIP and n-BFIP
groups the levels of CT, LDL-C and triglycerides were signifi-
cantly reduced suggesting that I. paraguariensis extracts, in this
preparation, can be very effective on this experimental model
of dyslipidemia. Despite the great effectiveness of this
extraction process in decreasing the serum lipid levels, the
n-BFIP (400 mg/kg) appears to be more effective than other
doses. This fact can be explained in part due to a possible
increase of active compounds in this dose and a possible
increase of antagonistic substances in high doses. Furthermore,
biological variability and the number of animals used in the
experiments also cannot be ruled out.
Another important parameter in the study of dyslipidemias
refers to atherosclerotic index (AI), which may indicate the
deposition of foam cells or plaque or fatty infiltration or lipids
in the heart, coronaries, aorta, liver and kidney. The higher the
atherosclerotic index the bigger the risk of these organs for
oxidative damage. Thus, the atherosclerotic index was signif-
icantly reduced in HEIP and n-BFIP HFD-treated rats, showing
the possible effects of these extracts in the prevention of
vascular dysfunction and atherosclerotic lesions, which can be
directly related to the reduction of plasma lipids.
New interesting works have emerged showing significant
effect of I. paraguariensis on bodyweight reduction both inmice
and in rat models. Recent data show that mate infusion has
potent anti-obesity activity in obese mice [42], and can show a
modulating effect on the expression of several genes related to
obesity [43,44]. Additionally, I. paraguariensis extracts have a
protective effect against HFD-induced obesity in rats through
an enhanced expression of uncoupling proteins and elevated
adenosine monophosphate (AMP) dependent kinase (AMPK)
phosphorylation in the visceral adipose tissue, given the central
role that this allosteric enzyme plays in energy metabolism
[26].
121S. Balzan et al. / Fitoterapia 86 (2013) 115–122Corroborating the above data, our findings also showed, in
addition to the effects on lipid levels, that both HEIP and n-BFIP
can be effective in reducing body weight of rats undergoing an
DHF, and showed for the first time, that the prolonged
administration of HEIP and its n-BFIP can reduce the CT, LDL-C,
VLDL-C and triglyceride levels very effectively, suggesting that
I. paraguariensis extracts (HEIP or n-BFIP) or their active
compound(s) could be helpful as an add-on to conventional
medicines. Furthermore, studies show that I. paraguariensis
infusion provides an additional LDL cholesterol reduction in
individuals on statin therapy, suggesting that the extracts can be
used to reduce the doses of statins and therefore the side effects
[28]. Nevertheless, further studies are required to elucidate the
mechanism of hypolipidemic action of this preparation, partic-
ularly the role of the phenolic compounds in atherogenesis
prevention.
In conclusion, these findings support the potential of HEIP or
n-BFIP from l. paraguariensis, as candidates to be phytomedicines
used in those cardiovascular diseases where lipid-lowering
effects are desired.
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